Title:
1H-IMIDAZO[4,5-B]PYRIDINYL AND 2-OXO-2,3-DIHYDRO-1H-IMIDAZO[4,5-B]PYRIDINYL HETEROCYCLIC BET BROMODOMAIN INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2017/103670
Kind Code:
A8
Abstract:
Substituted 1H-imidazo[4,5-b]pyridinyl and 2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridinyl heterocyclic compounds, which are useful as inhibitors of BET protein function by binding to bromodomains, compositions comprising said compounds, and their use in therapy are disclosed herein. These compounds are useful in the treatment of diseases and conditions, such as, cancer, autoimmune diseases, inflammation and cardiovascular diseases.
More Like This:
JP2010126530 | CONDENSED HETEROCYCLIC DERIVATIVE AND APPLICATION THEREOF |
JPH04234360 | NEW HERBICIDE |
WO/2022/040241 | A3 ADENOSINE RECEPTOR AGONISTS FOR USE IN MEDICINE |
Inventors:
BROWN SAMUEL DAVID (US)
KHARENKO OLESYA (CA)
KHARENKO OLESYA (CA)
Application Number:
PCT/IB2016/001874
Publication Date:
January 18, 2018
Filing Date:
December 14, 2016
Export Citation:
Assignee:
ZENITH EPIGENETICS LTD (CA)
International Classes:
C07D471/04; A61K31/437; A61K31/46; A61P35/00
Download PDF: